News and Views
Nature Medicine 13, 1411 - 1413 (2007)
doi:10.1038/nm1207-1411
Building the bionic T cell
Drew M Pardoll1
- Drew M. Pardoll is Abeloff Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA. e-mail: dmpardol@jhmi.edu
Abstract
Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440–1449).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Tumor reactive T cells get a boostNature Biotechnology Research News (01 Dec 2002)
Cancer T cell therapy expandsNature Medicine News and Views (01 Mar 2003)
RESEARCH
T cell?encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejectionNature Medicine Article (01 Dec 2007)
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120Gene Therapy Research Article
See all 5 matches for Research
